Related Experiment Video
Updated: Jul 13, 2026

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
Evaluation of ultra-performance liquid chromatography in the bioanalysis of small molecule drug candidates in plasma
Lee Goodwin1, Stephen A White, Neil Spooner
1Worldwide Bioanalysis, Glaxosmithkline Research and Development, Park Road,Ware, Hertfordshire, SG12 0DP, UK. lee.x.goodwin@gsk.com
Abstract:
Ultra-performance liquid chromatography (UPLC) combined with mass spectrometric detection (MS) is used successfully in the bioanalysis of small molecule drug candidates in plasma. UPLC-MS is shown to increase sample throughput by reducing run times over 3-fold, without compromising analytical sensitivity or analyte resolution. The technique is demonstrated to be practical and robust on a commercially available ultra-high pressure system when injecting extracts of plasma and has also shown to be a technique that can be used effectively on a conventional high-performance liquid chromatography system fitted with short columns (
Related Concept Videos
High-Performance Liquid Chromatography: Introduction
In HPLC, two phases play a critical role in the separation process:
High-Performance Liquid Chromatography: Elution Process
High-Performance Liquid Chromatography: Instrumentation
High-Performance Liquid Chromatography: Types of Detectors
Measurement of Bioavailability: Pharmacokinetic Methods
